Literature DB >> 16472121

Accelerated delimitation of the infarct zone by capillary-derived nestin-positive cells in aged rats.

Aurel Popa-Wagner1, Ivona Dinca, Suofu Yalikun, Lary Walker, Heyo Kroemer, Christof Kessler.   

Abstract

An important cellular event associated with reduced structural and functional recovery after stroke in aged animals is the early formation of a scar in the infarcted region that impairs neural recovery and repair. Despite the detrimental impact of infarct scar formation, the brain regions and cell types that supply the components of the scar are not well characterized. We hypothesized that premature cerebral scar formation in aged animals is associated with an altered cellular response to cerebral ischemia. Focal cerebral ischemia was produced by reversible occlusion of the right middle cerebral artery in 3 month- and 20 month-old male Sprague Dawley rats. After 3, 7, 14, and 28 days, brain tissue was subjected to real-time reverse-transcriptase-PCR (RT-PCR) and immunostaining for 1) a cellular proliferation marker (BrdU); 2) a neuroepithelial marker (nestin); 3) an astrocytic marker (glial fibrillary acidic protein [GFAP]); 4) a neuronal marker, doublecortin; and 5) a basal lamina marker (laminin), and analyzed using 3D-reconstruction of confocal images. In this model the infarct was localized primarily in the parietal cortex. By RT-PCR there was a robust increase in nestin mRNA transcripts shortly after stroke, and this increase was particularly intense in aged rats. Accordantly, we found in aged rats a rapid delimitation of the infarct area by nestin-positive cells and an early incorporation of these cells into the glial scar. The capillaries of the corpus callosum were the major source of proliferating, nestin-positive cells, many of which were also immunoreactive for doublecortin, although a smaller population of nestin cells were associated with the ventricular walls. Despite the proliferation of nestin cells, they did not make a significant contribution to neurogenesis in the infarcted cortex, possibly because the corpus callosum impedes the migration of subventricular zone-derived nestin-positive cells into the lesioned area. We conclude that: (i) the aged brain has the capability to mount a cytoproliferative response to injury, but the timing of the cellular and genetic reaction to cerebral insult is accelerated in aged animals; (ii) the proliferating cells contribute to the formation of the glial scar, but few of the cells appear to become neurons; and (iii) the vasculature plays a hitherto unrecognized role as a source of proliferating cells after stroke. Because capillary-derived cells help to form the glial scar, elucidating the molecular basis of this phenomenon and its acceleration in the aging brain could yield novel approaches to enhancing neurorestoration in the elderly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472121     DOI: 10.2174/156720206775541732

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  23 in total

Review 1.  Stem cell therapies in age-related neurodegenerative diseases and stroke.

Authors:  Yuan Wang; Xunming Ji; Rehana K Leak; Fenghua Chen; Guodong Cao
Journal:  Ageing Res Rev       Date:  2016-11-19       Impact factor: 10.895

2.  Age-dependent modifications in vascular adhesion molecules and apoptosis after 48-h reperfusion in a rat global cerebral ischemia model.

Authors:  Berta Anuncibay-Soto; Diego Pérez-Rodríguez; Irene L Llorente; Marta Regueiro-Purriños; José Manuel Gonzalo-Orden; Arsenio Fernández-López
Journal:  Age (Dordr)       Date:  2014-09-03

3.  Phosphatidylethanolamine Deficiency and Triglyceride Overload in Perilesional Cortex Contribute to Non-Goal-Directed Hyperactivity after Traumatic Brain Injury in Mice.

Authors:  Lisa Hahnefeld; Alexandra Vogel; Robert Gurke; Gerd Geisslinger; Michael K E Schäfer; Irmgard Tegeder
Journal:  Biomedicines       Date:  2022-04-15

4.  Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats.

Authors:  Zhenjun Tan; Xinlan Li; Ryan C Turner; Aric F Logsdon; Brandon Lucke-Wold; Kenneth DiPasquale; Soon Soeg Jeong; Ridong Chen; Jason D Huber; Charles L Rosen
Journal:  Eur J Pharmacol       Date:  2014-06-13       Impact factor: 4.432

5.  Plasminogen activator inhibitor type 1 derived peptide, EEIIMD, diminishes cortical infarct but fails to improve neurological function in aged rats following middle cerebral artery occlusion.

Authors:  Zhenjun Tan; Xinlan Li; Kimberly A Kelly; Charles L Rosen; Jason D Huber
Journal:  Brain Res       Date:  2009-05-22       Impact factor: 3.252

Review 6.  Neurovascular remodeling in the aged ischemic brain.

Authors:  Dirk M Hermann; Ana-Maria Buga; Aurel Popa-Wagner
Journal:  J Neural Transm (Vienna)       Date:  2013-12-31       Impact factor: 3.575

7.  Wogonin improves functional neuroprotection for acute cerebral ischemia in rats by promoting angiogenesis via TGF-β1.

Authors:  Zhaohong Kong; Qinglin Shen; Jian Jiang; Min Deng; Zhaohui Zhang; Gaohua Wang
Journal:  Ann Transl Med       Date:  2019-11

Review 8.  Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: A translational perspective.

Authors:  Eduardo Candelario-Jalil; Surojit Paul
Journal:  Exp Neurol       Date:  2020-10-07       Impact factor: 5.330

9.  Normobaric oxygen therapy attenuates hyperglycolysis in ischemic stroke.

Authors:  Zhe Cheng; Feng-Wu Li; Christopher R Stone; Kenneth Elkin; Chang-Ya Peng; Redina Bardhi; Xiao-Kun Geng; Yu-Chuan Ding
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

10.  Impact of age on the efficacy of bone marrow mononuclear cell transplantation in experimental stroke.

Authors:  Daniel-Christoph Wagner; Mitja Bojko; Myriam Peters; Marlene Lorenz; Cornelia Voigt; Alexander Kaminski; Dirk Hasenclever; Markus Scholz; Alexander Kranz; Gesa Weise; Johannes Boltze
Journal:  Exp Transl Stroke Med       Date:  2012-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.